News
What if one of the most promising compounds for colorectal cancer… isn’t a drug—but a cannabinoid most people have never even heard of?
CBG (the “mother cannabinoid”) is quietly showing powerful anti-tumor effects in early research—slowing cancer growth, triggering cell death, and targeting pathways specific to colon cancer. But here’s the catch: it doesn’t work in isolation.
The real shift happens when you combine targeted cannabinoids, gut-healing nutrition, and anti-inflammatory lifestyle changes into one strategic protocol. Because when it comes to colorectal cancer, healing isn’t about one miracle solution—it’s about changing the entire environment cancer depends on.
As most of you know, if you are purveyors of our blog, the endocannabinoid system regulates numerous physiological processes, these not only include the standard pain sensation, inflammation, and sleep and wake cycles – it is also known to moderate intestinal function, glucose metabolism, and the stress response. A poorly regulated endocannabinoid system is implicated in metabolic and bowel pathologies and many other diseases, the consequence of dramatic changes in the diets of modern-day humans from those of our ancestors. Today’s blog discusses the different and mutually beneficial roles of the cannabinoid receptors—CB1 and CB2—as it pertains to energy metabolism, digestion, and the role of diet.
Continue reading
